Sale!

ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the ARL6 gene responsible for Bardet-Biedl Syndrome Type 3. This advanced next-generation sequencing test identifies genetic variations that cause this rare autosomal recessive disorder affecting multiple organ systems including vision, kidney function, and endocrine regulation. The test is crucial for individuals experiencing symptoms like progressive vision loss, obesity, kidney abnormalities, and developmental delays. By providing definitive genetic diagnosis, this test enables personalized treatment strategies and informed family planning decisions. Results are available within 3-4 weeks using blood, extracted DNA, or blood spot samples. The test is priced at $500 USD with a regular price of $700 USD, making comprehensive genetic testing accessible for patients across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Inherited Disorders

The ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the ARL6 gene, which are responsible for Bardet-Biedl Syndrome Type 3. This rare autosomal recessive genetic disorder affects multiple organ systems and requires precise genetic confirmation for accurate diagnosis and management. Our advanced next-generation sequencing technology provides comprehensive analysis of the ARL6 gene, enabling healthcare providers to make informed clinical decisions and develop personalized treatment strategies.

What Does This Test Detect?

This specialized genetic test specifically targets and analyzes the ARL6 (ADP-ribosylation factor-like 6) gene using next-generation sequencing technology. The test identifies:

  • Pathogenic mutations in the ARL6 gene associated with Bardet-Biedl Syndrome Type 3
  • Single nucleotide variants (SNVs) and small insertions/deletions
  • Copy number variations affecting the ARL6 gene
  • Compound heterozygous and homozygous mutations
  • Novel genetic variants with potential clinical significance

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is recommended for individuals presenting with symptoms suggestive of Bardet-Biedl Syndrome or those with a family history of the condition. Key indications include:

  • Progressive vision loss or retinal dystrophy beginning in childhood
  • Obesity developing in early childhood
  • Polydactyly (extra fingers or toes)
  • Renal abnormalities or kidney dysfunction
  • Learning disabilities or developmental delays
  • Hypogonadism or reproductive system abnormalities
  • Diabetes mellitus or other endocrine disorders
  • Hepatic involvement or liver function abnormalities

Clinical Benefits of Genetic Testing

Undergoing the ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test provides numerous clinical advantages:

  • Definitive Diagnosis: Confirms or rules out Bardet-Biedl Syndrome Type 3 with high accuracy
  • Personalized Treatment: Enables targeted management strategies for affected organ systems
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management of potential complications
  • Differential Diagnosis: Helps distinguish from other ciliopathies with overlapping symptoms
  • Research Contribution: Advances understanding of rare genetic disorders

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your ARL6 gene status:

  • Positive Result: Identifies pathogenic mutations confirming Bardet-Biedl Syndrome Type 3 diagnosis
  • Negative Result: No disease-causing mutations detected, though clinical correlation is essential
  • Variant of Uncertain Significance (VUS): Genetic changes requiring further clinical evaluation
  • Carrier Status: Identification of individuals carrying one copy of mutated gene

All results are accompanied by detailed interpretation and genetic counseling recommendations to ensure proper understanding and next steps.

Test Pricing and Details

Test Component Details Price (USD)
Test Name ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test
Discount Price Limited Time Offer $500
Regular Price Standard Pricing $700
Turnaround Time Comprehensive Analysis 3-4 Weeks
Sample Type Multiple Options Available Blood, Extracted DNA, or Blood Spot on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services for patients throughout the country.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic conditions affect your quality of life. Our ARL6 Gene Bardet-Biedl Syndrome Type 3 NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic analysis, you can access world-class diagnostic testing without financial burden.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process.